Press Releases about Humanigen Inc
![](https://mms.businesswire.com/media/20220902005005/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://mms.businesswire.com/media/20220830005913/en/805463/5/business_Wire_Robbins_LLP.jpg)
![](https://mms.businesswire.com/media/20220829005725/en/538768/5/BES_Mark.jpg)
![](https://mms.businesswire.com/media/20220829005700/en/805463/5/business_Wire_Robbins_LLP.jpg)
![](https://mms.businesswire.com/media/20220829005558/en/1164042/5/July_30%2C_2021_-_ROSEN_LOGO.jpg)
![](https://mms.businesswire.com/media/20220829005528/en/827144/5/Schall-Firm-Logo-640x360.jpg)
![](https://mms.businesswire.com/media/20220827005007/en/827144/5/Schall-Firm-Logo-640x360.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Humanigen Reports Second Quarter 2022 Financial Results
August 12, 2022
From Humanigen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220719005880/en/827144/5/Schall-Firm-Logo-640x360.jpg)
![](https://mms.businesswire.com/media/20220718005836/en/827144/5/Schall-Firm-Logo-640x360.jpg)
![](https://mms.businesswire.com/media/20220712006186/en/1145764/5/Humanigen_Logo-04.jpg)
![](https://mms.businesswire.com/media/20220706005311/en/1145764/5/Humanigen_Logo-04.jpg)
![](https://mms.businesswire.com/media/20220630005489/en/1145764/5/Humanigen_Logo-04.jpg)
![](https://mms.businesswire.com/media/20220616005133/en/1145764/5/Humanigen_Logo-04.jpg)
![](https://mms.businesswire.com/media/20220603005155/en/1145764/5/Humanigen_Logo-04.jpg)
![](https://mms.businesswire.com/media/20220524005429/en/1145764/5/Humanigen_Logo-04.jpg)
![](https://mms.businesswire.com/media/20220505005996/en/1145764/5/Humanigen_Logo-04.jpg)
From Humanigen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220504005441/en/1145764/5/Humanigen_Logo-04.jpg)
![](https://mms.businesswire.com/media/20220419005500/en/1145764/5/Humanigen_Logo-04.jpg)
![](https://mms.businesswire.com/media/20220225005112/en/1145764/5/Humanigen_Logo-04.jpg)
From Humanigen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220211005044/en/1145764/5/Humanigen_Logo-04.jpg)
Humanigen to Present at BIO CEO & Investor Conference
February 11, 2022
From Humanigen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220209006129/en/1145764/5/Humanigen_Logo-04.jpg)
Humanigen Launches Managed Access Program for Lenzilumab
February 09, 2022
From Humanigen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220208006060/en/1145764/5/Humanigen_Logo-04.jpg)
From Humanigen, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220118005384/en/1145764/5/Humanigen_Logo-04.jpg)
![](https://mms.businesswire.com/media/20220110005281/en/1145764/5/Humanigen_Logo-04.jpg)
![](https://mms.businesswire.com/media/20220105005319/en/1145764/5/Humanigen_Logo-04.jpg)
![](https://mms.businesswire.com/media/20220104005383/en/1145764/5/Humanigen_Logo-04.jpg)
Humanigen to Present at Investor Conferences January 7 and 13, 2022
January 04, 2022
From Humanigen, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.